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Abstract
Background/Aim.  Atherosclerotic-occlusive changes
could be observed in orofacial branches of the external ca-
rotid artery. Atherosclerosis-induced ischemia caused al-
teration in production and release of endothelial factors.
The aim of this study was to investigate the influence of
carotid artery occlusion (10, 30 and 60 min) on vascular
effects of norepinephrine (NOR) and neuropeptide Y
(NPY) in the isolated glandular branch of the rabbit facial
artery, the main feeding artery for the submandibular
gland. Method. Changes in isometric tension were re-
corded in organ bath studies with arterial rings, before and
after carotid artery occlusion. Results. Concentration-
dependent vasocontractile effect of NOR was significantly
augmented after 30 and 60 min of carotid occlusion, but
only in the rings with intact endothelium.  Given alone,
NPY showed no effect in isolated glandular branch of the
rabbit facial artery, but enhanced NOR vasoconstriction in
all the investigated rings. NOR vasocontractile effect en-
hancement in the presence of NPY was attenuated after
30 and 60 min of carotid occlusion. Also, enhancement of
NOR vasoconstriction by NPY was significantly higher in
endothelium-intact rings compared to endothelium-
denuded rings obtained after 30 and 60 min of carotid oc-
clusion. Conclusion. The present investigation provides
results of increased vasocontractile effect of NOR and de-
creased enhancing effect of NPY on NOR vasoconstric-
tion in the rabbit facial artery after carotid occlusion that is
related to altered endothelium function.
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Apstrakt
Uvod/Cilj. Pokazano je da se okluzivne promene ateros-
kleroti?ne prirode mogu opaziti na orofacijalnim granama
spoljne karotidne arterije. Ishemija izazvana aterosklero-
zom, dovodi do poreme?aja stvaranja i osloba?anja faktora
poreklom iz endotela. Cilj ovog istraživanja bio je da se is-
pita uticaj okluzije karotidne arterije (10, 30 i 60 min) na
vazokontraktilne efekte norepinefrina (NOR) i neuropep-
tida Y (NPY) na izolovanoj žlezdanoj grani facijalne arte-
rije kuni?a, glavne dovodne arterije za submandibularnu
žlezdu. Metode. U kupatilu za izolovane krvne sudove is-
pitivane su izometrijske promene tonusa arterijskih prepa-
rata, pre i posle okluzije karotidne arterije. Rezultati.
Koncentracijski-zavisan vazokontraktilni efekat NOR bio
je zna?ajno ve?i posle 30 i 60 min karotidne okluzije, ali
samo na preparatima sa o?uvanim endotelom. Primenjen u
rastu?im koncentracijama, NPY nije imao efekta na tonus
izolovane žlezdane grane facijalne aterije kuni?a, ali je po-
ve?ao vazokontraktilni efekat NOR na svim ispitivanim
preparatima. Pove?anje vazokontraktilnog efekta NOR u
prisustvu NPY bilo je zna?ajno manje posle 30 i 60 min
okluzije. Tako?e, efekat NPY posle karotidne okluzije bio
je zna?ajno ve?i na preparatima sa o?uvanim endotelom u
odnosu na preparate sa uklonjenim endotelom. Zaklju-
?ak. Ovo istraživanje pokazalo je pove?anje vazokontrak-
tilnog efekta NOR i smanjenje potenciraju?eg efekta NPY
na vazokonstrikciju izazvanu NOR na facijalnoj arteriji
kuni?a posle okluzije karotidne arterije koje su povezane
sa promenjenom funkcijom endotela.
Klju?ne re?i:
neuropeptidi; noradrenalin; aa. carotis; okluzija;
ze?evi; vazokonstrikcija.
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Introduction
Salivary gland blood flow, mainly controlled by the
parasympathetic and sympathetic nervous system, signifi-
cantly contributes to salivary secretion. Cholinergic neuro-
transmitter, acetylcholine (ACh) and adrenergic, norepineph-
rine (NOR), are mainly responsible for vasodilatory and
vasoconstrictory responses in salivary glands, but also for the
important role in vascular regulation has non-adrenergic non-
cholinergic system involving: vasodilators such as vasoactive
intestinal polypeptide (VIP) and nitric oxide (NO), and vaso-
constrictors such as neuropeptide Y (NPY) and adenosine
triphosphate (ATP) 1–3. Immunohistochemistry revealed NPY
to be present around blood vessels and secretory parts in rat
and human submandibular gland, colocalized with NOR in
sympathetic nerves 4, 5. Previous studies showed that NPY
acts as vasoconstrictor and enhances the response to various
constrictor substances in a number of animal and human ar-
terial beds 6–8 . Moreover, some studies emphasize the sig-
nificance of NPY as a mediator strongly activated under
conditions of oxygen deprivation such as in ischemic coro-
nary artery disease 9, 10 . It is important to note that in nonis-
chemic tissues, vascular effect of NPY is mainly a result of
activation of NPY Y1 receptors, but under ischemia there
was an induction and upregulation of NPY Y2 receptors,
mainly involved in non-vasocontractile and angiogenic ac-
tivities of NPY 3, 11 .
Cellular function depends upon adequate oxygen sup-
ply. Oxygen deprivation as the result of ischemia of the
human vascular tissue plays the critical role in development
and progression of ischemic disorders 12. It is interesting to
note that atherosclerotic-occlusive changes could be ob-
served in human orofacial arteries which maintain local
blood flow in salivary glands , such as facial, maxillary and
lingual arteries, branches of external carotid artery. Under
experimental conditions, Vág et al. 14 have shown that ca-
rotid artery occlusion is followed by a decrease of subman-
dibular blood flow in rat, and associated with decreased NO
synthesis/release in intraglandular blood vessels. Ischemia
affects vascular function in terms of impairment of endo-
thelial function and alteration in production and release of
endothelium-derived vasodilators and vasoconstrictors, in
favor of the last one 15–18. A previous study in isolated
glandular branch of rabbit facial artery (feeding artery for
submandibular gland), after acute carotid occlusion, re-
vealed a decreased responsiveness to both, ACh-
endothelium-dependent and VIP-endothelium-independent
vasorelaxation after carotid occlusion as a result of im-
pairment of transduction signals including NO, prostaglan-
dins and cAMP 19.
Having in mind the impact of ischemia on endothelial
cell function and impairment of vasodilatory responses to
ACh and VIP in rabbit facial artery, we hypothesized that
acute ischemia would change sympathetic control of vascular
tone causing potentiation of vasocontractile responses of
NOR and NPY in isolated glandular branch of rabbit facial
artery. To test this hypothesis, we investigated the impact of
10, 30 and 60 min of carotid occlusion on vasocontractile ef-
fects of NOR and NPY, as well as involvement of endothe-
lium in these effects.
Methods
Animals and organ bath studies
The study was approved by the Ethical Committee of
the Faculty of Dental Medicine at the University of Belgrade.
The experiments were conducted on Chincilla rabbits (17
males and 5 females), aged 3 months, weighing 2.5–3.0 kg.
The animals were anesthetized using urethane (1g/kg iv).
Experimental ischemia was induced by left or right common
carotid artery occlusion by cords for 10, 30 or 60 min. After
the mentioned periods, the segments of occluded glandular
branch of facial artery and contralateral, nonoccluded (con-
trols) were dissected out and placed in Krebs-Ringer bicar-
bonate solution (37°C, pH = 7.4 gassed with 95% O2 and 5%
CO2). The endothelium was removed in some rings by wire.
After 60 min of equilibration, 1.0 g tension was applied and
segments stabilized for further 30 min. A Hugo Sachs model
MC 6621 recorder was used for isometric tension changes
registration.
Experimental protocol
Endothelium removal and functional integrity of arterial
segments were confirmed by the inability of segments to re-
lax (< 70%) to ACh (10 ?M) and by the ability to contract to
potassium-rich Krebs-Ringer solution (KCl = 60 mM). Con-
centration-response curves to NOR (0.1–10 ?M), alone, and
30 min after incubation with NPY (0.1 ?M ), were obtained
in endothelium-intact and endothelium-denuded arterial
segments. In another group of experiments, vascular effect of
cumulative concentrations of NPY (0.01–0.3 ?M) was in-
vestigated.
Drugs
All the compounds were obtained from Sigma–Aldrich,
St. Louis, USA. All the drugs were dissolved in distilled
water and prepared as the final concentrations for the 150 ?L
of bath solution.
Statistics
The vasoconstriction induced by each concentration of
NOR and NOR+NPY was expressed as a percent constric-
tion of Krebs-Ring solution (KCl = 60mM)-induced maximal
constriction. The maximal effect (Emax) and the concentration
of the agonist which produced half of Emax (pEC50 = -
log EC50) for each concentration-response curve were ob-
tained in nonlinear regression analysis (GraphPad Prism
software). The results were expressed as ? ± S.E.M.; n refers
to the number of experiments. The results of comparison of
vascular effects of NPY, in the control and the occluded
rings, were calculated as differences of area under the con-
centration–response curves (AUC) for NOR, obtained in the
presence or absence of NPY, in control and experimental
situation. In this way, we were able to integrate effects of
NPY and carotid occlusion, both affecting vasoconstriction.
The AUC was calculated from each cumulative concentra-
Volumen 71, Broj 6 VOJNOSANITETSKI PREGLED Strana 573
Roganovi? J, et al. Vojnosanit Pregl 2014; 71(6): 571–575.
tion-response curve before, and after 10, 30 and 60 min of
carotid occlusion (GraphPad Prism software). The results
were analyzed using Student's t-test for paired and unpaired
observations and analyses of variance (one way ANOVA
followed by a Dunnet's post hoc test or two way ANOVA
followed by a Bonferroni's correction). The significance was
considered from a value of p < 0.05.
Results
NOR (0.1–10 ?M) induced concentration-dependent
constriction in the rabbit facial arterial rings with and with-
out endothelium is shown in Figure 1. The maximal vaso-
contractile effect of NOR (10 ?M) was significantly aug-
mented in endothelium-denuded compared to endothelium-
intact rings but with no change in pEC50 (100.5 ± 5.5%;
pEC50 = 6.07 ± 0.07 compared to 76.0 ± 4.2%; pEC50 =
5.91 ± 0.02, respectively). After 30 and 60 min of carotid oc-
clusion, significant augmentation of maximal vasocontractile
effect (Emax) to NOR was observed in endothelium-intact but
not in denuded rings, while pEC50 remain unchanged (Tables
1 and 2). The values of AUC for NOR-induced vasocon-
striction in endothelium-intact rings were augmented also in
rings after 30 and 60 min, but not after 10 min of occlusion
(Figure 2).
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Fig. 2 – The area under curve (AUC) values for norepi-
nepheine (NOR) on endothelium-intact rabbit facial arterial
rings before and after 10, 30 and 60 min of carotid occlusion.
Each column represents the ? ± S.E.M. from 5 experiments.
*p < 0.05; **p < 0.01 compared to the AUC for NOR
vasoconstriction obtained in rings before carotid occlusion
(one-way ANOVA with Dunnet's post hoc test).
Given in increasing concentrations, NPY (0.01–0.3 ?M)
showed no effect on the resting tone of the isolated glandular
branch of the rabbit facial artery, before and after carotid ar-
tery occlusion, regardless the endothelium presence.
Fig. 1 – Concentration-response curves for norepinephrine
(NOR) in the rabbit facial arterial rings with the intact (?)
and denuded endothelium (?). Each point represents the ?
± S.E.M from 5 experiments. The responses are expressed
as percent contraction of maximal contraction induced by
60 mM KCl. *p < 0.05; **p < 0.01 endothelium-denuded in
comparison with endothelium-intact rings (Student's t test
for unpaired observations).
Table 1
Maximal effect (Emax) of norepinephrine in endothelium-intact and -denuded rings
before and after 10, 30 and 60 min of carotid artery occlusion
Emax (%), ? ± S.E.M.Carotid artery occlusion (min) endothelium-intact rings endothelium-denuded rings
0 76.0 ± 4.2 100.5 ± 5.5†
10 82.6 ± 4.5 108.7 ± 6.3†
30 131.5± 5.6†* 90.4± 4.5
60 145.5 ± 4.5†** 107.4 ± 6.5
 *p < 0.05 ; **p < 0.01 (rings before vs rings after carotid occlusion); †p < 0.05 (endothelium-intact vs -denuded rings).
Table 2
pEC50 values of norepinephrine in endothelium-intact and -denuded rings
before and after 10, 30 and 60 min of carotid artery occlusion
pEC50Carotid artery occlusion (min) endothelium-intact rings endothelium-denuded rings
0 5.91 ± 0.02 6.07 ± 0.07
10 5.90 ± 0.05 6.00 ± 0.03
30 6.00 ± 0.04 5.86 ± 0.07
60 6.09 ± 0.03 5.95 ± 0.03
EC50 – concentration producing half of maximal effect (Emax)
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In the presence of NPY (0.1 ?M), vasocontractile effect
to NOR was significantly enhanced in all the investigated
rings obtained before and after 10, 30 and 60 min of carotid
occlusion (data not shown). The comparison of dAUC values
showed that enhancement of NOR vasocontractile effect in
the presence of NPY was attenuated after 30 and 60 min of
occlusion, in endothelium-denuded rings, as well as after 60
min of occlusion in endothelium-intact rings. Also, enhanc-
ing effect of NPY was significantly higher in endothelium-
intact compared to endothelium-denuded rings obtained after
30 and 60 min but not after 10 min of carotid occlusion (Fig-
ure 3).
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Fig. 3 – Potentiation of norepinepheine (NOR)-mediated va-
soconstriction in rabbit facial arterial rings [calculated as
the percentual differences of the area curve (AUC) for NOR]
in the presence of neuropeptide Y (NPY), before and after
10, 30 and 60 min of carotid artery occlusion. Each column
represents the ? ± S.E.M. from 6 experiments.
*p < 0.05, **p < 0.01 compared to d (AUC) (%) obtained in
the rings before carotid artery occlusion;
?p < 0.05 endothelium-denuded in comparison with endot-
helium-intact rings
(two-way ANOVA with Bonferroni correction).
Discussion
The results of the present functional study add new in-
sights into the impact of different time of carotid artery oc-
clusion duration as well as of endothelium on vascular ef-
fects to NOR and NPY in the glandular branch of the rabbit
facial artery. Our study showed that NOR-induced concen-
tration-dependent vasoconstriction in the glandular branch of
the isolated rabbit facial artery was significantly enhanced in
endothelium-denuded compared to endothelium-intact arte-
rial rings. These results suggest that under non-ischemic
conditions in this artery, the presence of endothelium influ-
ences the effect of NOR and partly masks it, most probably
as a result of endothelium release of vasodilator substances,
as seen in other arterial beds 20, 21. Carotid artery occlusion
affects the vasocontractile effect of NOR only in endothe-
lium-intact rings and time-dependently: 10 min was without
effect while it was most pronounced after 60 min of carotid
occlusion. In the endothelium-intact rings, but not in the de-
nuded, after 30 and 60 min of carotid occlusion vasocontrac-
tile effect of NOR was found to be significantly enhanced
compared to the matched rings obtained before carotid oc-
clusion. Furthermore, the present results show that carotid
occlusion affected responsiveness, measured by Emax, but no
sensitivity, measured by pEC50, to NOR. It implies that is-
chemic enhancement of the effect of NOR is rather a result
of altered signalling in dysfunctional endothelium than an
alteration at the receptor level suggesting the significant role
of ischemia-altered endothelium in vasoconstriction induced
by NOR in rabbit facial arterial rings after carotid occlusion.
Moreover, the fact that in endothelium-denuded rings the ef-
fect of carotid artery occlusion on NOR vasoconstriction was
not observed, implies that vascular smooth muscle-derived
vasoconstrictors are not involved in the observed ischemic
alteration of the effect of NOR.
It is well-known that, under physiological conditions, the
resting arterial tone is under the control of endothelium and
balanced release of vasodilators and vasoconstrictors derived
from endothelium, while under conditions of ischemia, this
balance is altered in favor of vasoconstrictors due to endothe-
lial dysfunction 22. Recently, in the glandular branch of the
rabbit facial artery, the results showed that 30 and 60 min of
carotid occlusion resulted in the impairment of endothelium
function and decreased ACh-endothelium-dependent vasore-
laxation 19. The suggested underlying mechanism included a
decrease in endothelial NO production/release and a con-
comitant increased involvement of cyclooxygenase (COX) 19.
Having in mind the increased function of NPY under
ischemic conditions 9 we investigated the impact of ex-
perimentally-induced ischemia on NPY effect in the glan-
dular branch of the rabbit facial artery. In the present in-
vestigation, NPY, given alone in increasing doses, had no
effect in the glandular branch of facial artery neither before
nor after carotid occlusion. However, NPY significantly in-
creased NOR effect in this artery, under ischemic and non-
ischemic conditions, regardless of endothelium presence.
Thus, NPY alone is not a potent vasoconstrictor in the rab-
bit facial artery, but requires a tone to contract, similarly to
some other arterial beds such as mesenteric artery of rat
and ear artery of rabbit 23, 24. Comparison of dAUC values
showed that under ischemia, enhancing effects of NPY on
NOR vasoconstriction decreased in the isolated rabbit fa-
cial artery. One possible reason for this could be lying in
the fact that under ischemia, expression and activity of
NPY Y2 receptors in vascular smooth muscle are increased
11 and that, contrary to activation of NPY Y1, activation of
these receptors opposes constriction 25. Although NPY-
mediated enhancement of NOR vasocontractile effect
shows no difference in rabbit endothelium-intact compared
to denuded facial rings before carotid occlusion, after 30
and 60 min of occlusion, enhancement of NOR vasocon-
striction by NPY is higher in endothelium intact compared
to denuded rings. This could be due to increased endothe-
lium-release of vasoconstrictors which could contribute to
NPY effect , but some studies also point out the fact that
endothelium per se could synthesize NPY or internalize
sympathetically-derived NPY and release it under some
circumstances, such as artery occlusion 26, 27.
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Conclusion
Having in mind the significance of sympathetically-
regulated salivary gland blood flow for salivary gland func-
tion, our results provide some new findings concerning NOR
and NPY vascular effects on the main feeding artery for
submandibular gland under ischemic conditions. This could
be important for clarifying mechanisms of endothelial dys-
function underlying salivary gland diseases related to ische-
mic circulatory disorders.
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